PLEC and neoplasm: Consistent with our in vitro observations, MRI analysis at 4, 6, and 9 wk post-induction revealed that both genetic and pharmacological plectin inactivation results in a substantial reduction in the average tumor number per mouse and the tumor incidence (Figure 7A).